Meteorologist Debunks TIME Mag’s Claim That Jan 2024 Was Hottest On Record

Climate Lie Debunked

An article in TIME Magazine (TIME) claims that January 2024 was the hottest ever on record for the planet. Titled, 2024 Had the Hottest January on Record Following 2023’s Hottest Year on Record the article is based on a single source of temperature data.

Data from multiple other sources of temperature measurements refute this claim. [emphasis, links added]

TIME refers to the Copernicus EU climate service as the source for its alarming claim. Copernicus EU issued a press release claiming:

January 2024 was the warmest January on record globally, with an average ERA5 surface air temperature of 13.14°C, 0.70°C above the 1991-2020 average for January and 0.12°C above the temperature of the previous warmest January, in 2020.

The month was 1.66°C warmer than an estimate of the January average for 1850-1900, the designated pre-industrial reference period.

The problem with that is that they are using a reference period of 1850 to 1900 that no other climate data source uses; a period, not coincidentally, more than 100 years of global warming ago when the Earth was cooler than today.

For example, NASA Goddard Institute for Space Studies (GISS) produced a map of the globe that shows a significantly lower global temperature for January 2024.

The GISS global value was just 1.20°C compared to the 1.66°C claimed by Copernicus is different because NASA GISS is using a base period of 1951 to 1980.

Copernicus seemingly cherry-picked the reference period to fit the climate crisis narrative, and TIME was too uninterested in seeking and presenting the truth to investigate the extraordinary claim, instead reporting it as an unchallenged fact.

When you look at satellite temperature data compiled by the University of Alabama in Huntsville (UAH), the “hottest January ever” claim also falls apart:

The satellite’s global temperature value is just 0.86°C, essentially half of what Copernicus claims at 1.66°C.

While it is not the globe, the United States (U.S.) is often cited as being a leading metric for climate change by both media and scientific sources. This is because the U.S. has more temperature stations per land area than any other region included in the global climatological network.

As such, its readings have an outsized impact on global average temperature measurements.

Yet when you examine the data from the US Climate Reference Network (USCRN), the best and most state-of-the-art surface measurement system in the world, we find that not only was January 2024 not the hottest on the record it was below normal in temperature:

At -0.14°F (-0.08°C), there is certainly no cause for alarm about temperature in the United States. Yet TIME does not mention any of these other sources.

It gets worse than the simple subversion of science by omission of critical facts. TIME quoted a spokesperson for Copernicus in the article:

Rapid reductions in greenhouse gas emissions are the only way to stop global temperatures increasing,” Samantha Burgess, deputy director of the Copernicus Climate Change Service, said in a statement.

That statement is nothing more than political advocacy calling for the reduction of greenhouse gases through restrictions of economies, rather than simply reporting the science. By using that quote, TIME is complicit in pushing advocacy over science.

https://climatechangedispatch.com/meteorologist-debunks-time-mags-claim-that-jan-2024-was-hottest-on-record/

B vitamins slow Alzheimer’s brain atrophy seven-fold

Amid a devastating epidemic stealing minds and memories, a new study suggests an astonishing 7-fold reduction in Alzheimer’s brain atrophy from a shockingly simple treatment: high-dose B vitamins.

With over 6 million Americans living with Alzheimer’s disease and no FDA-approved treatments that effectively slow its progression, there is a desperate need for new therapeutic strategies. Despite billions invested in developing medications targeting Alzheimer’s brain plaques and tangles, drug trial after drug trial has ended in disappointment. But an unlikely natural treatment – high doses of three humble B vitamins – may succeed where these drugs have failed.

A groundbreaking new study published in the Proceedings of the National Academy of Sciences (Douaud et al., 2013) suggests that high-dose B vitamin treatment could slow the progression of Alzheimer’s disease by as much as 7-fold. The double-blind randomized controlled trial included 156 elderly patients with mild cognitive impairment (MCI), an early Alzheimer’s risk state. Patients who took supplements of folic acid, vitamins B6 and B12 over two years had dramatically less brain atrophy detected via MRI scans compared to patients taking a placebo. Critically, the treatment was most effective in patients with elevated homocysteine levels. By lowering this amino acid, B vitamins reduced grey matter loss in brain regions vulnerable in Alzheimer’s.

The results provide a glimmer of hope amid the litany of failed Alzheimer’s clinical trials. Unlike risky experimental drugs designed to remove plaques or tangles, vitamin B supplements are safe, natural, and already indicated for high homocysteine levels. If these unprecedented findings are confirmed in ongoing trials, vitamin supplementation could offer the first major advancement in Alzheimer’s treatment in over 15 years. With cases expected to triple in coming decades, this affordable regimen could have tremendous potential to alleviate the staggering burden of this epidemic.

© February 8th 2024 GreenMedInfo LLC. This work is reproduced and distributed with the permission of GreenMedInfo LLC. Want to learn more from GreenMedInfo? Sign up for the newsletter here www.greenmedinfo.com/greenmed/newsletter.

https://nexusnewsfeed.com/article/health-healing/b-vitamins-slow-alzheimer-s-brain-atrophy-seven-fold/

B vitamins slow Alzheimer’s brain atrophy seven-fold

Alzheimers Brain Atrophy

Amid a devastating epidemic stealing minds and memories, a new study suggests an astonishing 7-fold reduction in Alzheimer’s brain atrophy from a shockingly simple treatment: high-dose B vitamins.

With over 6 million Americans living with Alzheimer’s disease and no FDA-approved treatments that effectively slow its progression, there is a desperate need for new therapeutic strategies.1 Despite billions invested in developing medications targeting Alzheimer’s brain plaques and tangles, drug trial after drug trial has ended in disappointment.2 But an unlikely natural treatment – high doses of three humble B vitamins – may succeed where these drugs have failed.

A groundbreaking new study published in the Proceedings of the National Academy of Sciences (Douaud et al., 2013)3 suggests that high-dose B vitamin treatment could slow the progression of Alzheimer’s disease by as much as 7-fold. The double-blind randomized controlled trial included 156 elderly patients with mild cognitive impairment (MCI)4, an early Alzheimer’s risk state. Patients who took supplements of folic acidvitamins B6 and B12 over two years had dramatically less brain atrophy detected via MRI scans compared to patients taking a placebo. Critically, the treatment was most effective in patients with elevated homocysteine levels.5 By lowering this amino acid, B vitamins reduced grey matter loss in brain regions vulnerable in Alzheimer’s.6

The results provide a glimmer of hope amid the litany of failed Alzheimer’s clinical trials.7 Unlike risky experimental drugs designed to remove plaques or tangles, vitamin B supplements are safe, natural, and already indicated for high homocysteine levels. If these unprecedented findings are confirmed in ongoing trials, vitamin supplementation could offer the first major advancement in Alzheimer’s treatment in over 15 years.8 With cases expected to triple in coming decades, this affordable regimen could have tremendous potential to alleviate the staggering burden of this epidemic.9

© February 8th 2024 GreenMedInfo LLC. This work is reproduced and distributed with the permission of GreenMedInfo LLC. Want to learn more from GreenMedInfo? Sign up for the newsletter here www.greenmedinfo.com/greenmed/newsletter.

https://nexusnewsfeed.com/article/health-healing/b-vitamins-slow-alzheimer-s-brain-atrophy-seven-fold/

Our understanding of COVID-19 vaccinations and their impact on health and mortality has evolved substantially since the first vaccine rollouts.

Published reports from the original randomized phase 3 trials concluded that the COVID-19 mRNA vaccines could greatly reduce COVID-19 symptoms. In the interim, problems with the methods, execution, and reporting of these pivotal trials have emerged. Re-analysis of the Pfizer trial data identified statistically significant increases in serious adverse events (SAEs) in the vaccine group. Numerous SAEs were identified following the Emergency Use Authorization (EUA), including death, cancer, cardiac events, and various autoimmune, hematological, reproductive, and neurological disorders. Furthermore, these products never underwent adequate safety and toxicological testing in accordance with previously established scientific standards. Among the other major topics addressed in this narrative review are the published analyses of serious harms to humans, quality control issues and process-related impurities, mechanisms underlying adverse events (AEs), the immunologic basis for vaccine inefficacy, and concerning mortality trends based on the registrational trial data.

The risk-benefit imbalance substantiated by the evidence to date contraindicates further booster injections and suggests that, at a minimum, the mRNA injections should be removed from the childhood immunization program until proper safety and toxicological studies are conducted. Federal agency approval of the COVID-19 mRNA vaccines on a blanket-coverage population-wide basis had no support from an honest assessment of all relevant registrational data and commensurate consideration of risks versus benefits.

Given the extensive, well-documented SAEs and unacceptably high harm-to-reward ratio, we urge governments to endorse a global moratorium on the modified mRNA products until all relevant questions pertaining to causality, residual DNA, and aberrant protein production are answered.

https://www.cureus.com/articles/203052-covid-19-mrna-vaccines-lessons-learned-from-the-registrational-trials-and-global-vaccination-campaign

Bananas

Banana: I’m not ripe yet.
Banana: I’m not ripe yet.
Banana: I’m not ripe yet.
Banana whispering at 3AM: I’ m r i p e.
Banana at 8AM same morning: HAHAHA I’m soooooo rotten!
Welcome to Brown Town.